dimarts, 19 de maig del 2015

Philips Respironics responds to ResMed trial data

Philips says it's examining data from ResMed showing increased risk of death to see if it will affect Respironics sleep apnea device patients.

Philips Respironics responds to ResMed trial data

read more



from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1S8hiWO

Cap comentari:

Publica un comentari a l'entrada